Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells

被引：55

作者：

Plano, Daniel ^{[1
]}

Sanmartin, Carmen ^{[1
]}

Moreno, Esther ^{[1
]}

Prior, Celia ^{[2
]}

Calvo, Alfonso ^{[2
]}

Palop, Juan Antonio ^{[1
]}

机构：

[1] Univ Navarra, Dept Quim Organ & Farmaceut, Secc Sintesis, E-31008 Pamplona, Spain

[2] Univ Navarra, CIMA, Ctr Appl Med Res, Div Oncol, E-31008 Pamplona, Spain

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 24期

关键词：

organoselenium; cytotoxics; prostate;

D O I：

10.1016/j.bmcl.2007.10.022

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of 17 symmetrical substituted imidothiocarbamate and imidoselenocarbamate derivatives has been synthesized by reacting appropriately substituted acyl chlorides with alkyl imidothiocarbamates and alkyl imidoselenocarbamates. The antitumoral activities of the compounds were evaluated in vitro by examining their cytotoxic effects against human prostate cancer cells (PC-3). Five compounds showed interesting activity levels and 3p (IC50 = 1.85 mu M) was 7.3 times more active than the standard etoposide used in the treatment of prostate cancer and emerges as the most interesting compound. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：6853 / 6859

页数：7

共 50 条

[21] Clinical and Novel Biomarkers in the Management of Prostate Cancer
Sanhueza, Cristobal
Kohli, Manish
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (02)
[22] Clinical and Novel Biomarkers in the Management of Prostate Cancer
Cristóbal Sanhueza
Manish Kohli
Current Treatment Options in Oncology, 2018, 19
[23] Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-α
Cooper, Carlton R.
Graves, Bianca
Pruitt, Freddie
Chaib, Hassan
Lynch, Jill E.
Cox, Andrew Koemeter
Sequeria, Linda
van Golen, Kenneth L.
Evans, Angelo
Czymmek, Kirk
Bullard, Rebecca S.
Donald, Carlton D.
Sol-Church, Katia
Gendernalik, James D.
Weksler, Babette
Farach-Carson, Mary C.
Macoska, Jill A.
Sikes, Robert A.
Pienta, Kenneth J.
JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (06) : 2298 - 2309
[24] Inhibition of vascular endothelial cells by 1,4-phenylenebis (methylene)selenocyanate - A novel chemopreventive organoselenium compound
Schumacher, JJ
Upadhyaya, P
Ramakrishnan, S
ANTICANCER RESEARCH, 2001, 21 (3B) : 1945 - 1951
[25] Histone Modifications, Stem Cells and Prostate Cancer
Crea, Francesco
Clermont, Pier-Luc
Mai, Antonello
Helgason, Cheryl D.
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (11) : 1687 - 1697
[26] Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer
Araldi, Elena M. V.
Dell'Aica, Isabella
Sogno, Ilaria
Lorusso, Girieca
Garbisa, Spiridione
Albini, Adriana
CURRENT CANCER DRUG TARGETS, 2008, 8 (02) : 146 - 155
[27] INTRODUCTORY-REMARKS - DEVELOPMENT OF CHEMOPREVENTIVE AGENTS FOR PROSTATE-CANCER
KELLOFF, GJ
BOONE, CW
MALONE, WF
STEELE, VE
DOODY, LA
JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, : 1 - 8
[28] The role of chemotherapy and new targeted agents in the management of primary prostate cancer
Kumar, Sanjeev Srinivas
Pacey, Simon
JOURNAL OF CLINICAL UROLOGY, 2016, 9 (02) : 30 - 37
[29] Novel cyclotides from Hedyotis diffusa induce apoptosis and inhibit proliferation and migration of prostate cancer cells
Hu, Enping
Wang, Dongguo
Chen, Jiayu
Tao, Xiulin
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4059 - 4065
[30] Prostate stem cells: From development to cancer
Signoretti, Sabina
Loda, Massimo
SEMINARS IN CANCER BIOLOGY, 2007, 17 (03) : 219 - 224

← 1 2 3 4 5 →